Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1975 1
1987 1
1990 1
1992 1
1993 1
1994 1
1995 2
1996 2
1997 2
1998 4
1999 1
2000 3
2001 1
2002 6
2003 1
2004 1
2005 1
2006 2
2007 1
2008 5
2009 1
2010 2
2011 5
2012 4
2013 5
2014 3
2015 6
2016 8
2017 3
2018 5
2019 5
2020 6
2021 14
2022 5
2023 3
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

101 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Classic Hodgkin lymphoma, lymphocyte-rich type"
Page 1
ROBUST: A Phase III Study of Lenalidomide Plus R-CHOP Versus Placebo Plus R-CHOP in Previously Untreated Patients With ABC-Type Diffuse Large B-Cell Lymphoma.
Nowakowski GS, Chiappella A, Gascoyne RD, Scott DW, Zhang Q, Jurczak W, Özcan M, Hong X, Zhu J, Jin J, Belada D, Bergua JM, Piazza F, Mócikova H, Molinari AL, Yoon DH, Cavallo F, Tani M, Yamamoto K, Izutsu K, Kato K, Czuczman M, Hersey S, Kilcoyne A, Russo J, Hudak K, Zhang J, Wade S, Witzig TE, Vitolo U. Nowakowski GS, et al. J Clin Oncol. 2021 Apr 20;39(12):1317-1328. doi: 10.1200/JCO.20.01366. Epub 2021 Feb 23. J Clin Oncol. 2021. PMID: 33621109 Free PMC article. Clinical Trial.
PURPOSE: Patients with the activated B-cell-like (ABC) subtype of diffuse large B-cell lymphoma (DLBCL) historically showed inferior survival with standard rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP). ...RESULTS: A total of 570 patien …
PURPOSE: Patients with the activated B-cell-like (ABC) subtype of diffuse large B-cell lymphoma (DLBCL) historically showed inferior …
Management of limited-stage Hodgkin lymphoma.
Al-Juhaishi T, Ahmed S. Al-Juhaishi T, et al. Hematology Am Soc Hematol Educ Program. 2023 Dec 8;2023(1):500-509. doi: 10.1182/hematology.2023000511. Hematology Am Soc Hematol Educ Program. 2023. PMID: 38066938 Free article.
Hodgkin lymphoma (HL) is a rare type of B-cell malignancy with bimodal age distribution targeting young adults and elderly. ...Outcomes are generally excellent with standard chemotherapy or combined modality therapy. Balancing efficacy and the risk of late effects i …
Hodgkin lymphoma (HL) is a rare type of B-cell malignancy with bimodal age distribution targeting young adults and elderly. .. …
Cutaneous lymphoma: Kids are not just little people.
Ferenczi K, Makkar HS. Ferenczi K, et al. Clin Dermatol. 2016 Nov-Dec;34(6):749-759. doi: 10.1016/j.clindermatol.2016.07.010. Epub 2016 Jul 10. Clin Dermatol. 2016. PMID: 27968935 Review.
Cutaneous T-cell lymphomas (CTCLs) are non-Hodgkin lymphomas that predominantly affect older patients. Onset of cutaneous lymphoma in childhood is rare, but it can present as early as the first decade of life. ...The prognosis is stage dependent, and the most …
Cutaneous T-cell lymphomas (CTCLs) are non-Hodgkin lymphomas that predominantly affect older patients. Onset of cutaneous lymphoma …
Lymphocyte predominant Hodgkin's disease.
Ekstrand BC, Horning SJ. Ekstrand BC, et al. Curr Oncol Rep. 2002 Sep;4(5):424-33. doi: 10.1007/s11912-002-0037-8. Curr Oncol Rep. 2002. PMID: 12162918 Review.
Lymphocyte predominant Hodgkin's disease (LPHD) is a rare type of B-cell lymphoma with unique pathologic and clinical features that distinguish it from other types of Hodgkin's disease. ...The immunophenotype of the malignant lymphocytic …
Lymphocyte predominant Hodgkin's disease (LPHD) is a rare type of B-cell lymphoma with unique pathologic and cli …
Spatially Resolved Tumor Microenvironment Predicts Treatment Outcomes in Relapsed/Refractory Hodgkin Lymphoma.
Aoki T, Jiang A, Xu A, Yin Y, Gamboa A, Milne K, Takata K, Miyata-Takata T, Chung S, Rai S, Wu S, Warren M, Strong C, Goodyear T, Morris K, Chong LC, Hav M, Colombo AR, Telenius A, Boyle M, Ben-Neriah S, Power M, Gerrie AS, Weng AP, Karsan A, Roth A, Farinha P, Scott DW, Savage KJ, Nelson BH, Merchant A, Steidl C. Aoki T, et al. J Clin Oncol. 2024 Mar 20;42(9):1077-1087. doi: 10.1200/JCO.23.01115. Epub 2023 Dec 19. J Clin Oncol. 2024. PMID: 38113419 Free PMC article.
PURPOSE: About a third of patients with relapsed or refractory classic Hodgkin lymphoma (r/r CHL) succumb to their disease after high-dose chemotherapy followed by autologous stem-cell transplantation (HDC/ASCT). ...For each cell type in the TME, we ca …
PURPOSE: About a third of patients with relapsed or refractory classic Hodgkin lymphoma (r/r CHL) succumb to their d …
Management of elderly patients with malignant lymphoma.
Miyazaki K. Miyazaki K. Jpn J Clin Oncol. 2022 Jul 8;52(7):690-699. doi: 10.1093/jjco/hyac056. Jpn J Clin Oncol. 2022. PMID: 35435235
A comprehensive geriatric assessment is a potential tool for determining an appropriate therapeutic approach for each older patient. Follicular lymphoma is the second most common type of non-Hodgkin lymphoma, and the disease course is usually ch …
A comprehensive geriatric assessment is a potential tool for determining an appropriate therapeutic approach for each older patient. Follicu …
Pathology and "molecular histology' of Hodgkin's disease and the border to non-Hodgkin's lymphomas.
Hansmann ML, Küppers R. Hansmann ML, et al. Baillieres Clin Haematol. 1996 Sep;9(3):459-77. doi: 10.1016/s0950-3536(96)80021-7. Baillieres Clin Haematol. 1996. PMID: 8922240 Review.
Diffuse paragranuloma may be difficult to differentiate from classic HD as well as non-Hodgkin's lymphomas, especially T-cell-rich B-cell lymphomas and peripheral T-cell lymphomas. In rare cases a distinction between HD and non-Hodgkin's lymphomas may …
Diffuse paragranuloma may be difficult to differentiate from classic HD as well as non-Hodgkin's lymphomas, especially T-cell- …
Nodal Involvement by CD30(+) Cutaneous Lymphoproliferative Disorders and Its Challenging Differentiation From Classical Hodgkin Lymphoma.
Lezama LS, Gratzinger D. Lezama LS, et al. Arch Pathol Lab Med. 2018 Jan;142(1):139-142. doi: 10.5858/arpa.2016-0352-RS. Arch Pathol Lab Med. 2018. PMID: 29257929 Free article. Review.
Primary cutaneous lymphomas are defined as non-Hodgkin lymphomas that present in the skin with no evidence of extracutaneous disease at the time of diagnosis. ...Nodal involvement by CD30(+) T-cell lymphoproliferative disorders can mimic classical Hodgkin …
Primary cutaneous lymphomas are defined as non-Hodgkin lymphomas that present in the skin with no evidence of extracutaneous disea …
Identification of prognostic factors in classic Hodgkin lymphoma by integrating whole slide imaging and next generation sequencing.
Santisteban-Espejo A, Bernal-Florindo I, Perez-Requena J, Atienza-Cuevas L, Catalina-Fernandez I, Fernandez-Valle MDC, Romero-Garcia R, Garcia-Rojo M. Santisteban-Espejo A, et al. Mol Omics. 2022 Dec 5;18(10):1015-1028. doi: 10.1039/d2mo00195k. Mol Omics. 2022. PMID: 36382626
Algorithms for quantifying cell populations in the lymph node and genetics can be integrated to identify new biomarkers with prognostic impact in classic Hodgkin lymphoma (cHL). In 16 cHL patients, we have performed whole slide imaging (WSI) analysis a …
Algorithms for quantifying cell populations in the lymph node and genetics can be integrated to identify new biomarkers with prognostic …
T-cell-rich B-cell lymphoma.
Rodriguez J, Pugh WC, Cabanillas F. Rodriguez J, et al. Blood. 1993 Sep 1;82(5):1586-9. Blood. 1993. PMID: 8364208 Free article.
Sixty-five percent of all cases were referred with other diagnosis such as Hodgkin's mixed cellularity, peripheral T-cell lymphoma (PTCL), or diffuse mixed lymphoma, and had received therapy accordingly. ...Age, sex, and beta 2-microglobulin were not signific …
Sixty-five percent of all cases were referred with other diagnosis such as Hodgkin's mixed cellularity, peripheral T-cell lymphoma …
101 results